270 related articles for article (PubMed ID: 33035672)
1. Seroprevalence of SARS-CoV-2 immunoglobulin antibodies in Wuhan, China: part of the city-wide massive testing campaign.
Pan Y; Li X; Yang G; Fan J; Tang Y; Hong X; Guo S; Li J; Yao D; Cheng Z; Yuan Y; Li Y; Wang X
Clin Microbiol Infect; 2021 Feb; 27(2):253-257. PubMed ID: 33035672
[TBL] [Abstract][Full Text] [Related]
2. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence and asymptomatic carrier status of SARS-CoV-2 in Wuhan City and other places of China.
Duan S; Zhou M; Zhang W; Shen J; Qi R; Qin X; Yu H; Zhou C; Hu Q; Yu XJ
PLoS Negl Trop Dis; 2021 Jan; 15(1):e0008975. PubMed ID: 33411805
[TBL] [Abstract][Full Text] [Related]
4. Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak-the CoNAN study.
Weis S; Scherag A; Baier M; Kiehntopf M; Kamradt T; Kolanos S; Ankert J; Glöckner S; Makarewicz O; Hagel S; Bahrs C; Kimmig A; Proquitté H; Guerra J; Rimek D; Löffler B; Pletz MW;
Clin Microbiol Infect; 2021 Mar; 27(3):470.e1-470.e9. PubMed ID: 33221432
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study.
He Z; Ren L; Yang J; Guo L; Feng L; Ma C; Wang X; Leng Z; Tong X; Zhou W; Wang G; Zhang T; Guo Y; Wu C; Wang Q; Liu M; Wang C; Jia M; Hu X; Wang Y; Zhang X; Hu R; Zhong J; Yang J; Dai J; Chen L; Zhou X; Wang J; Yang W; Wang C
Lancet; 2021 Mar; 397(10279):1075-1084. PubMed ID: 33743869
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of IgM and IgG Antibodies against SARS-CoV-2 in Asymptomatic People in Wuhan: Data from a General Hospital Near South China Seafood Wholesale Market during March to April in 2020.
Ling RJ; Yu YH; He JY; Zhang JX; Xu S; Sun RR; Zhu WC; Chen MF; Li T; Ji HL; Wang HQ
Biomed Environ Sci; 2021 Sep; 34(9):743-749. PubMed ID: 34530966
[TBL] [Abstract][Full Text] [Related]
7. Public screening for COVID-19 in Wuhan, China and beware of the antibody positive in women and tumor patients.
Shang Y; Liang Y; Liu T; Li J; Zhou F
J Med Virol; 2022 Apr; 94(4):1535-1539. PubMed ID: 34850404
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.
Poustchi H; Darvishian M; Mohammadi Z; Shayanrad A; Delavari A; Bahadorimonfared A; Eslami S; Javanmard SH; Shakiba E; Somi MH; Emami A; Saki N; Hormati A; Ansari-Moghaddam A; Saeedi M; Ghasemi-Kebria F; Mohebbi I; Mansour-Ghanaei F; Karami M; Sharifi H; Pourfarzi F; Veisi N; Ghadimi R; Eghtesad S; Niavarani A; Ali Asgari A; Sadeghi A; Sorouri M; Anushiravani A; Amani M; Kaveh S; Feizesani A; Tabarsi P; Keyvani H; Markarian M; Shafighian F; Sima A; Sadjadi A; Radmard AR; Mokdad AH; Sharafkhah M; Malekzadeh R
Lancet Infect Dis; 2021 Apr; 21(4):473-481. PubMed ID: 33338441
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of antibodies to SARS-CoV-2 among blood donors in China.
Chang L; Hou W; Zhao L; Zhang Y; Wang Y; Wu L; Xu T; Wang L; Wang J; Ma J; Wang L; Zhao J; Xu J; Dong J; Yan Y; Yang R; Li Y; Guo F; Cheng W; Su Y; Zeng J; Han W; Cheng T; Zhang J; Yuan Q; Xia N; Wang L
Nat Commun; 2021 Mar; 12(1):1383. PubMed ID: 33654063
[TBL] [Abstract][Full Text] [Related]
10. Serological investigation of asymptomatic cases of SARS-CoV-2 infection reveals weak and declining antibody responses.
Yang Y; Wang X; Du RH; Zhang W; Si HR; Zhu Y; Shen XR; Li Q; Li B; Men D; Zhou YN; Wang H; Tong XL; Zhang XE; Shi ZL; Zhou P
Emerg Microbes Infect; 2021 Dec; 10(1):905-912. PubMed ID: 33870851
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Antibody Seroprevalence in Wuhan, China, from 23 April to 24 May 2020.
Han H; Yi J; Cheng G; Jiang W; Brożek GM; Jiang Y; Zhu C; Xia Y
mSphere; 2021 Apr; 6(2):. PubMed ID: 33883260
[TBL] [Abstract][Full Text] [Related]
12. Positive Rate of Serology and RT-PCR for COVID-19 among Community Residents and Healthcare Workers in Wuhan, China.
He L; Zeng Y; Zeng C; Zhou Y; Li Y; Xie X; Xu W; Luo W; Hu J; Yi Z; Wang X; Tang S; Xu L; Chen C
Jpn J Infect Dis; 2021 Jul; 74(4):333-336. PubMed ID: 33390427
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 outbreak in Milan.
Valenti L; Bergna A; Pelusi S; Facciotti F; Lai A; Tarkowski M; Lombardi A; Berzuini A; Caprioli F; Santoro L; Baselli G; Ventura CD; Erba E; Bosari S; Galli M; Zehender G; Prati D;
Blood Transfus; 2021 May; 19(3):181-189. PubMed ID: 33539289
[TBL] [Abstract][Full Text] [Related]
14. Screening and Analysis of SARS-CoV-2 Antibody Among Unvaccinated Blood Donors in Chongqing, China.
Jiang Y; Huang L; Liao H; Luo C; Zhang C; Mao W
Disaster Med Public Health Prep; 2024 May; 18():e85. PubMed ID: 38699831
[TBL] [Abstract][Full Text] [Related]
15. Severe Acute Respiratory Syndrome Coronavirus 2 Viral RNA Load Status and Antibody Distribution Among Patients and Asymptomatic Carriers in Central China.
Yuan Y; Wang H; Zhao J; Jing N; Xu J; Li W; Ma B; Zhang J; Li G; Wang S; Li Y; Wang Y; Fan E; Li L
Front Cell Infect Microbiol; 2021; 11():559447. PubMed ID: 33816325
[TBL] [Abstract][Full Text] [Related]
16. Highlighted Prospects of an IgM/IgG Antibodies Test in Identifying Individuals With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.
Li Y; He Q; Yu R; Jiang H; Wang W; Feng D; Hou G; Zhou H; Jiang Y; Xiang Z
Arch Pathol Lab Med; 2021 Jan; 145(1):39-45. PubMed ID: 32966561
[TBL] [Abstract][Full Text] [Related]
17. Antibody tests for identification of current and past infection with SARS-CoV-2.
Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
[TBL] [Abstract][Full Text] [Related]
18. Analysis of adjunctive serological detection to nucleic acid test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis.
Liu R; Liu X; Yuan L; Han H; Shereen MA; Zhen J; Niu Z; Li D; Liu F; Wu K; Luo Z; Zhu C
Int Immunopharmacol; 2020 Sep; 86():106746. PubMed ID: 32619956
[TBL] [Abstract][Full Text] [Related]
19. The absence of coronavirus in expressed prostatic secretion in COVID-19 patients in Wuhan city.
Zhang S; Wang X; Zhang H; Xu A; Fei G; Jiang X; Tu J; Qu G; Xu X; Li Y
Reprod Toxicol; 2020 Sep; 96():90-94. PubMed ID: 32534021
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of SARS-CoV-2 Infection in Portugal in May-July 2020: Results of the First National Serological Survey (ISNCOVID-19).
Kislaya I; Gonçalves P; Barreto M; Sousa R; Garcia AC; Matos R; Guiomar R; Rodrigues AP;
Acta Med Port; 2021 Feb; 34(2):87-94. PubMed ID: 33641702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
